Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357238 · ClinicalTrials.gov registry record
Genetics of Uveitis
A clinical trial of Uveitis and Infectious Uveitis, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT02357238: Recruiting study of Uveitis and Infectious Uveitis, sponsored by The Cleveland Clinic.
NCT02357238 is a study of Uveitis and Infectious Uveitis that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 1,500 participants, above the 539-participant average among 19 other Uveitis trials with a reported enrollment target (178% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02357238, a study of Uveitis and Infectious Uveitis, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.
Primary Outcome
Distinct uveitis conditions will have a polymorphism association or specific mutation.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2011-01 |
| Est. Completion | 2030-01 |
What NCT02357238 shows while recruiting
NCT02357238 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 539-participant average among 19 other Uveitis trials with a reported enrollment target (178% higher).
The record links to 2 conditions, with Uveitis appearing as the primary indexed condition, and to 0 interventions.
NCT02357238 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02357238 about?
NCT02357238 is a clinical study titled "Genetics of Uveitis". In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.
What is the current status of trial NCT02357238?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2011-01. Estimated completion is 2030-01.
What conditions does trial NCT02357238 study?
This clinical trial studies the following conditions: Uveitis, Infectious Uveitis.
Who is sponsoring clinical trial NCT02357238?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02357238 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02357238's enrollment target sits among peer trials
1,500 2nd of 19 higher than 17 of 19 other Uveitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uveitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING
-
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
-
Imaging Quantification of Inflammation (IQI)
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia